Gabitril and Roxicodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabitril (tiagabine hydrochloride) and Roxicodone (oxycodone hydrochloride). Common drug interactions include arthralgia among females and drug dependence among males.

The phase IV clinical study analyzes what interactions people have when they take Gabitril and Roxicodone. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Gabitril?

Gabitril has active ingredients of tiagabine hydrochloride. It is often used in epilepsy. eHealthMe is studying from 2,230 Gabitril users. Check the latest studies of Gabitril.

What is Roxicodone?

Roxicodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 20,099 Roxicodone users. Check the latest studies of Roxicodone.



On Jul, 28, 2026

11 people who take Gabitril and Roxicodone together, and have interactions are studied.

Gabitril and Roxicodone drug interactions.

What are the common drug interactions of Gabitril and Roxicodone, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Abdominal tenderness
  3. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Coital bleeding (bleeding after sexual intercourse)
  6. Constipation
  7. Delusional disorder, unspecified type
  8. Depression
  9. Drug dependence
  10. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

male:

  1. Drug dependence
  2. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Obesity (having too much body fat)
  5. Oedema peripheral (superficial swelling)
  6. Overdose
  7. Renal disorder (kidney disease)
  8. Renal mass (mass in kidney)
  9. Spinal cord neoplasm (tumour of spinal cord)
  10. Cardiovascular disorder (heart diseases)

What are the common drug interactions of Gabitril and Roxicodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug abuser
  2. Drug dependence
  3. Ejaculation disorder
  4. Erectile dysfunction
  5. Facial bones fracture (bone fracture of face)
  6. Male sexual dysfunction (impaired sexual function in male)
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Physical assault
  9. Respiratory tract congestion (blockage on respiratory system)
  10. White blood cell count decreased

40-49:

  1. Abdominal tenderness
  2. Arthralgia (joint pain)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Coital bleeding (bleeding after sexual intercourse)
  5. Constipation
  6. Delusional disorder, unspecified type
  7. Depression
  8. Drug dependence
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

50-59:

  1. Oedema peripheral (superficial swelling)
  2. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  3. Arthralgia (joint pain)
  4. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  5. Cardiovascular disorder (heart diseases)
  6. Hypokalaemia (low potassium)
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  8. Pain in extremity
  9. Tumour marker increased
  10. Anaemia (lack of blood)

60+:

n/a

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
  2. Breast Cancer Stage Iii: 2 people, 18.18%
  3. Blood Pressure Abnormal: 2 people, 18.18%
  4. Thyroid Diseases: 1 person, 9.09%
  5. Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
  6. Memory Loss: 1 person, 9.09%
  7. Indigestion: 1 person, 9.09%
  8. Bone Disorder: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Gabitril and Roxicodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabitril and Roxicodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabitril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Roxicodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabitril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Roxicodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tiagabine hydrochloride and oxycodone hydrochloride (the active ingredients of Gabitril and Roxicodone, respectively), and Gabitril and Roxicodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: